12 GHP Q3 2026 n the rapidly evolving landscape of health and biotechnology, Astrobiome® stands out as a trailblazer, earning the prestigious GHP Global Excellence Award as the Most Innovative Microbiome Therapeutics Company 2026. By fusing advanced space biotechnology with ancient Japanese fermentation mastery, Astrobiome is redefining microbiome science through its groundbreaking Super-Postbiotics™, naturally produced fullspectrum metabolite complexes designed to support human health and longevity, with applications for regenerative agriculture both on Earth and beyond. Founded in 2023 in Luxembourg, Astrobiome Space, SARL (with original HQ in Houston, TX, USA), the company leverages extreme environments to create dynamic metabolic therapeutic solutions. Its mission is clear: upgrade human health and food systems to survive long-duration space missions, while delivering extraordinary benefits to humanity on Earth facing climate uncertainty and health decline. Drawing on over 30 years of studies in extreme conditions, including collaborations with institutions like the National Aeronautics and Space Administration(NASA), the Luxembourg Space Agency (LSA), and the European Space Agency (ESA), Astrobiome Space uses proprietary methods to expose the selected bacterial strains to the unique stresses of microgravity. Utilizing the access to the International Space Station (ISS) laboratory, the company optimizes metabolite production in microgravity and has discovered new bioactive compounds that can only be achieved from these types of strains through stimulation in the space environment. This results in space-adapted Champion Strains™ that generate more than 600 detectable bioactive metabolites in synergistic harmony. Unlike traditional probiotics, these stable postbiotics – which contain no live bacteria – deliver bioactive compounds via skin or direct digestive absorption. They support deep microbiome balance, intestinal barrier integrity, immune modulation, nutrient absorption, and systemic health without added sugar. Key benefits, testified by users and backed by the company’s clinical tests, include enhanced gut-brain axis function (improved mood, focus, and reduced anxiety/ADHD symptoms), deeper sleep and recovery, reduced inflammation and joint pain, better blood sugar regulation, liver support, energy restoration, and overall cellular resilience — even against stressors like radiation. Testimonials from astronauts, athletes, NASA engineers, post-partum moms, and everyday users highlight transformative effects on immunity, digestion, vitality, and longevity. I Awarded with the title of Most Innovative Microbiome Therapeutics Company 2026 in this year’s Global Excellence Awards, Astrobiome Space is an extraordinary, award-winning business making a positive impact on the integral health and biotechnology sphere. We take a closer look below. Astrobiome®’s approach is rooted in precision fermentation in partnering Tokyo labs, including Tokyo University and Kyoto University, inspired by Blue Zones centenarians and combined with space-enhanced evolution. This yields highquality, consistent, superior postbiotic formulations that are shelf-stable and suitable for sensitive systems. The company’s work extends beyond human therapeutics: its microbiomebased biostimulants support regenerative agriculture, soil remediation, and plant resilience – with successful experiments like strawberry growth in space via Luxembourg Space Agency (LSA) LuxImpulse collaborations. Previous accolades, including Top Agri Biotech Solutions Provider (2024), Space Impact Hall of Fame recognition, and multiple LSA partnerships, underscore Astrobiome’s leadership at the intersection of microbiome science, epigenetics, postbiotics, and astrobiology. As microbiome research reveals the gut’s central role in immunity, metabolism, mental well-being, and aging, Astrobiome Space positions postbiotics as the next frontier, moving beyond symptom management toward proactive, cellular-level regeneration and healthy longevity. Its innovations promise to transform human wellness and advance sustainable farming practices critical for Earth and future space missions. To make this complex technology accessible for everyday lives, the company is expanding the Astrobiome-INSIDE™ concept, inviting food and beverage companies to collaborate on the first postbiotic-integrated snacks, super-foods, and premium cosmetics. Vera Mulyani, CEO and Founder, emphasizes transitioning from chemical-dependent systems to natural microbiome solutions to address climate and health challenges. With its 2026 GHP recognition, Astrobiome exemplifies how bold scientific vision, rooted in space research and traditional wisdom, can deliver innovative therapeutics that nourish life at every level. For more on Astrobiome®’s Super-Postbiotics™ and mission, visit the website today. The real meaning of the buzzword “longevity” is experienced here with Astrobiome® — resilient, regenerative, and ready for humanity’s greatest challenges. Contact: Vera Mulyani Company: Astrobiome Space Website: https://astrobiome.space/ Astrobiome Space: Pioneering the Next Era of Microbiome Therapeutics
RkJQdWJsaXNoZXIy MTUyMDQwMA==